On the basis of data aailable from published clinical trials, statin therapy is associated with a small excess risk of transaminase eleations, but not of myalgias, creatine kinase eleations, rhabdomyolysis, or withdrawal of therapy compared with placebo.

• 基于可利用的临床试验数据，与安慰剂比较，他汀类治疗存在转氨酶升高的风险，却与肌痛、肌酸激酶升高、横纹肌溶解或者终止用药无关。